AI assistant
Axogen, Inc. — Director's Dealing 2014
May 12, 2014
32414_dirs_2014-05-12_f7f1b4ce-6f10-4968-9a65-71bdd0a729ae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2013-01-01
Reporting Person: Mandato Joseph M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-05 | Common Stock | A | 15000 | $2.64 | Acquired | 30000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-01 | Stock Option (Right to Buy) | $2.75 | A | 13000 | Acquired | 2020-01-01 | Common Stock (13000) | Direct |
| 2014-01-02 | Stock Option (Right to Buy) | $4.81 | A | 15000 | Acquired | 2014-01-02 | Common Stock (15000) | Direct |
Footnotes
F1: Price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $2.62 to $2.65 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F2: Annual option grant as compensation for service on the board of directors. All options vested on the date of grant.
F3: Annual option grant as compensation for service on the board of directors. Options vest as to 25% of total shares at the end of each fiscal quarter, becoming fully vested after one year.